REP. JENKINS SECURES $1.3M FOR NAS TREATMENT
July 12, 2018
Line-item funding for areas like West Virginia where NAS rates exceed the national average
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) has secured $1.3 million to treat neonatal abstinence syndrome, the first time NAS has received line-item funding in an appropriations bill.
This funding means NAS joins fetal alcohol syndrome, sickle cell anemia, epilepsy and oral health as the only conditions to receive line-item funding under the Special Projects of Regional and National Significance. This funding is included in the Labor, Health and Human Services appropriations bill passed by the House Appropriations Committee late Wednesday.
“Nothing is more heartbreaking than hearing the cries of babies going through withdrawal from heroin and other opioids. Newborns are the most vulnerable victims of this epidemic, and this legislation will help us better understand the scope of this epidemic and help to ensure these babies have a healthy start to life,” Rep. Jenkins said.
This new funding will be used for areas where reported NAS rates exceed the national average.
Rep. Jenkins also secured two additional provisions related to NAS. The first urges the Centers for Disease Control and Prevention to expand its studies of the long-term effects of NAS on children diagnosed at birth. The second provision asks for an update from the Department of Health and Human Services on the implementation of NAS best practices.
The bill also funds other important West Virginia priorities, including:
- $12 million for black lung clinics.
- $515 million for opioid overdose prevention and surveillance.
- $3.85 billion to address substance abuse.
- Including $1 billion for state opioid response grants.